ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Epstein-Barr virus (EBV)"

  • 2017 American Transplant Congress

    Presence of Anellovirus Nucleic Acid Sequences in Involved Tissue Is Associated with Worse Patient Survival in Post-Transplant Lymphoproliferative Disorder.

    V. Dharnidharka, R. Chen, M. Ruzinova, P. Parameswaran, H. O'Gorman, K. Wylie, G. Storch.

    Washington University in St Louis School of Medicine, St. Louis

    Introduction: PTLD remain a feared complication of organ and tissue transplant, with high morbidity and mortality. While 50-80% of cases are strongly associated with Epstein-Barr…
  • 2017 American Transplant Congress

    Rituximab Desensitization (DES) and Alemtuzumab Induction Significantly Reduced EBV Viremia and Post-Transplant Lymphoproliferative Disorder (PTLD) in HLA-Sensitized (HS) Kidney Transplant Patients.

    B.-H. Shin,1 S. Ge,1 J. Mirocha,2 D. Thomas,1 E. Rodriguez,1 C. Chao,1 O. Galera,1 A. Vo,1 J. Choi,1 A. Peng,1 J. Kahwaji,1 S. Jordan,1 M. Toyoda.1

    1Transplant Immunology Laboratory and Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA; 2Biostatistics Core, Cedars-Sinai Medical Center/UCLA School of Medicine, Los Angeles, CA

    Background: PTLD is a serious complication in KTx pts and is usually associated with EBV infection. Recent studies showed that rituximab treatment prior to Tx…
  • 2017 American Transplant Congress

    Risk of Primary Central Nervous System Lymphoma in Solid Organ Transplant Recipients.

    E. Engels, P. Mahale, M. Shiels.

    National Cancer Institute, Bethesda, MD

    Background: Risk of primary central nervous system lymphoma (PCNSL) is greatly increased in immunosuppressed HIV-infected people. Case series describe PCNSL in solid organ transplant (SOT)…
  • 2017 American Transplant Congress

    Does EBV Viremia at Time of Transplant Have a Negative Impact on Transplant Outcomes?

    P. Verghese, H. Balfour, D. Schmeling, J. Grimm, S. Chinnakotla, A. Matas.

    University of Minnesota, Minneapolis

    Being EBV antibody (Ab) positive at the time of transplant increases the risk of post-transplant lymphoproliferative disorder (PTLD) and is a significant threat to patient…
  • 2017 American Transplant Congress

    Generation of Autologous CMV and EBV-Specific T-Cell Lines from Seronegative Patients for Cell Therapy of Opportunistic Infections Following Kidney Transplantation.

    C. Lamarche,1 T. Pincez,1 J. Orio,1 C. Carli,1 A. Humar,2 J.-S. Delisle.1

    1Centre de Recherche de l'Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada; 2Toronto General Research Institute, Toronto, ON, Canada

    Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) reactivations after kidney transplant are associated with substantial morbidity, especially in seronegative patients. Adoptive immunotherapy using virus-specific T cells…
  • 2017 American Transplant Congress

    Post-Transplant Lymphoproliferative Disorder: Risk Analysis for Pancreas Transplant Patients.

    E. Minja, T. Dunn, A. Matas, T. Pruett, R. Kandaswamy, E. Finger.

    Dept of Surgery, University of Minnesota, Minneapolis, MN

    Objective: Determine incidence, risk factors, and impact of PTLD in pancreas transplantation (PTx).Methods: Retrospective review of all PTx performed between 7/25/1978 and 12/17/2015 at a…
  • 2017 American Transplant Congress

    Simultaneous Pancreas/Kidney Transplant Recipients Are Predisposed to Symptomatic CMV-Infection and Concomitant Infectious Complications.

    T. Schachtner,1,2,3 M. Zaks,1 A. Kahl,1 P. Reinke.1,2

    1Nephrology and Internal Intensive Care, Charite Campus Virchow Clinic, Berlin, Germany; 2Berlin-Brandenburg Center for Regenerative Therapies, Charite Campus Virchow Clinic, Berlin, Germany; 3Berlin Institute of Health BIH, Berlin, Germany

    Infections have increased in simultaneous pancreas/kidney transplant recipients (SPKTRs) with CMV-infection being the most important viral infection with adverse impact on patient and allograft outcomes.…
  • 2017 American Transplant Congress

    In Depth Characterization of the Innate Immune Response in Transplant Recipients with EBV Viremia.

    V. Ferreira, J. Batist, D. Kumar, S. Husain, A. Humar.

    UHN, Toronto, Canada

    Background:Infection with Epstein-Barr virus (EBV) manifests as a spectrum of disease ranging from asymptomatic viremia to PTLD. Innate immune cells such as monocytes/macrophages, dendritic cells…
  • 2017 American Transplant Congress

    Lymphoproliferative Disorders After Renal Transplantation Along Two Decades: A Large Longitudinal Study.

    A. Franco,1 D. Hernandez,2 N. Maruri,3 A. Alonso,4 M. Crespo,5 A. Mazuecos,6 C. Diaz-Corte,7 M. Gentil.8

    1Nephrology, Hospital General, Alicante, Spain; 2Nephrology, Hospital Carlos Haya, Málaga, Spain; 3Nephrology, Hospital Cruces, Bilbao, Spain; 4Nephrology, Hospital Universitario, A Coruña, Spain; 5Nephrology, Hospital del Mar, Barcelona, Spain; 6Nephrology, Hospital Puerta del Mar, Cadiz, Spain; 7Nephrology, Hospital General, Oviedo, Spain; 8Nephrology, Hospital Virgen del Rocío, Sevilla, Spain

    In a longuitudinal study,we evaluated the cumulative incidence of Posttransplant limphoproliferative disorders(PTLD),its relationship with Epstein Barr Virus (EBV),classical risk factors and outcome in 21546 single…
  • 2017 American Transplant Congress

    BK Virus, Cytomegalovirus and Epstein-Barr Virus Reactivation in Renal Transplant Patients: Results from a Large Multicenter Study.

    A. Blázquez-Navarro,1 C. Dang-Heine,1 M. Or-Guil,2 C. Bauer,3 T. Westoff,4 C. Hugo,5 P. Reinke,1 B. Sawitzki,1 N. Babel.1,4

    1Berlin-Brandenburg Center for Regenerative Therapies, Berlin, Germany; 2Humboldt-Universität zu Berlin, Berlin, Germany; 3MicroDiscovery GmbH, Berlin, Germany; 4Medizinische Klinik I, Universitätsklinikum der Ruhr-Universität Bochum, Herne, Germany; 5Medizinische Klinik III, Universitätsklinikum Carl Gustav Carus, Dresden, Germany

    The purpose of this study was to ascertain the prevalence and clinical implications of three of the most relevant opportunistic infections in kidney transplantation, namely…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences